Efficacy and Safety of Adipose Stem Cell Culture Supernatant Extract for Skin Ulcers
- Conditions
- skin ulcer
- Registration Number
- JPRN-jRCTs043230043
- Lead Sponsor
- akagawa Masahiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
1. men and women between 18 and 90 years of age
2. patients with various types of skin ulcers (excluding head and face)
3. patients with skin ulcers with a maximum diameter of 1 cm or more but less than 9 cm
4. patients whose consent to participate in this study has been obtained by signing a consent form by the patient or a proxy.
1. patients with vasculitic ulcers
2. patients requiring inpatient treatment for ulcers
3. patients with severe anemia or thrombocytopenia
4. patients with infection at the site of ulcer and tendency to exacerbation
5. patients with malignant tumors at the ulcer site
6. patients requiring surgical procedures such as amputation or skin grafting (not including debridement)
7. patients receiving continuous oral or injectable steroid hormone therapy
8. patients with severely impaired nutritional status
9. patients undergoing dialysis or immunosuppression
10. who has a history of allergy to adipose stem cell culture supernatant extract
11. patients who have been deemed unsuitable by the principal investigator or a subinvestigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method